File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: A point mutation in CD28 distinguishes proliferative signals from survival signals

TitleA point mutation in CD28 distinguishes proliferative signals from survival signals
Authors
Issue Date2001
Citation
Nature Immunology, 2001, v. 2, n. 4, p. 325-332 How to Cite?
AbstractUpon interaction with its ligand, B7, CD28 becomes phosphorylated on tyrosines. One tyrosine in particular (Y170 in mouse CD28, Y173 in human CD28) has received much attention. This is because it permits CD28 to recruit SH2-containing signaling molecules, including phosphoinositide 3 kinase, Grb2 and Gads. Using mice we employed a transgenic approach to express a tyrosine→phenylalanine mutant form of CD28 that uncouples these SH2-mediated interactions from CD28.The CD28 mutant is unable to up-regulate expression of the prosurvival protein Bcl-xL, rendering the T cells more susceptible to radiation-induced death. Nonetheless, this mutated form of CD28 still prevents the induction of anergy and promotes T cell proliferation, interleukin 2 secretion and B cell help. Thus, we describe a single point mutation within the CD28 cytoplasmic domain that uncouples signals required for proliferation and survival.
Persistent Identifierhttp://hdl.handle.net/10722/291568
ISSN
2021 Impact Factor: 31.250
2020 SCImago Journal Rankings: 9.074
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorOkkenhaug, Klaus-
dc.contributor.authorWu, Linda-
dc.contributor.authorGarza, Kristine M.-
dc.contributor.authorLa Rose, Jose-
dc.contributor.authorKhoo, Wilson-
dc.contributor.authorOdermatt, Bernhard-
dc.contributor.authorMak, Tak W.-
dc.contributor.authorOhashi, Pamela S.-
dc.contributor.authorRottapel, Robert-
dc.date.accessioned2020-11-17T14:54:39Z-
dc.date.available2020-11-17T14:54:39Z-
dc.date.issued2001-
dc.identifier.citationNature Immunology, 2001, v. 2, n. 4, p. 325-332-
dc.identifier.issn1529-2908-
dc.identifier.urihttp://hdl.handle.net/10722/291568-
dc.description.abstractUpon interaction with its ligand, B7, CD28 becomes phosphorylated on tyrosines. One tyrosine in particular (Y170 in mouse CD28, Y173 in human CD28) has received much attention. This is because it permits CD28 to recruit SH2-containing signaling molecules, including phosphoinositide 3 kinase, Grb2 and Gads. Using mice we employed a transgenic approach to express a tyrosine→phenylalanine mutant form of CD28 that uncouples these SH2-mediated interactions from CD28.The CD28 mutant is unable to up-regulate expression of the prosurvival protein Bcl-xL, rendering the T cells more susceptible to radiation-induced death. Nonetheless, this mutated form of CD28 still prevents the induction of anergy and promotes T cell proliferation, interleukin 2 secretion and B cell help. Thus, we describe a single point mutation within the CD28 cytoplasmic domain that uncouples signals required for proliferation and survival.-
dc.languageeng-
dc.relation.ispartofNature Immunology-
dc.titleA point mutation in CD28 distinguishes proliferative signals from survival signals-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1038/86327-
dc.identifier.pmid11276203-
dc.identifier.scopuseid_2-s2.0-0035319244-
dc.identifier.volume2-
dc.identifier.issue4-
dc.identifier.spage325-
dc.identifier.epage332-
dc.identifier.isiWOS:000167982900013-
dc.identifier.issnl1529-2908-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats